Aurinia Pharmaceuticals Inc. Gains 26.75%
Fri, Oct 22, 2021 at 05:32 PM
Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ) shot up at $28, a gain of 26.8%. On Thu, Oct 21, 2021, AUPH:NASDAQ hit a New 2-Week High of $22.09. The stock appeared on our News Catalysts scanner on Fri, Oct 22, 2021 at 05:26 PM in the 'ACQUISITION' category. From Thu, Oct 07, 2021, the stock recorded 60.00% Up Days and 63.64% Green Days
The stock spiked on Tue, Sep 21, 2021 at $24.18 with a volume of 7M+, and its share price has been moving sideways in recent weeks.
About Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ)
Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. The Company is engaged in the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis.
Top 10 Gainers:
- Phunware, Inc. (PHUN:NASDAQ), 471.24%
- Remark Holdings, Inc. (MARK:NASDAQ), 138.44%
- CCAI (CCAI:NASDAQ), 100%
- REVE (REVE:NASDAQ), 100%
- SG Blocks, Inc. (SGBX:NASDAQ), 42.43%
- CRTD (CRTD:NASDAQ), 41.44%
- PTLO (PTLO:NASDAQ), 28.63%
- GROM (GROM:NASDAQ), 28.45%
- Yunhong CTI Ltd. (CTIB:NASDAQ), 27.58%
- Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ), 26.75%